Reducing off-target expression of mRNA therapeutics and vaccines in the liver with microRNA binding sites
Lipid nanoparticles (LNPs) are often liver tropic, presenting challenges for LNP-delivered mRNA therapeutics intended for other tissues, as off-target expression in the liver may increase side effects and modulate immune responses. To avoid off-target expression in the liver, miR-122 binding sites h...
Saved in:
| Main Authors: | Brian J. Parrett, Satoko Yamaoka, Michael A. Barry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050124002183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue
by: N Matyasovska, et al.
Published: (2025-04-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01) -
Click chemistry-based dual nanosystem for microRNA-122 detection with single-base specificity from tumour cells
by: Agustín Robles-Remacho, et al.
Published: (2024-12-01) -
MicroRNA as a Potential Biomarker for Amyotrophic Lateral Sclerosis (ALS)
by: José Augusto Nogueira-Machado, et al.
Published: (2025-05-01) -
MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control
by: Kaito Masaki, et al.
Published: (2025-09-01)